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I. Introduction 
Socio-Economic Impact of Cognitive Decline: 
 
 As the baby boomer generation reaches retirement, geriatric Americans are 
becoming a much larger portion of the United States’ population. The 2018 U.S. Census 
estimated that 15.6% of the American population is over the age of sixty-five.  This 
number translates to over 51 million people in the United States over sixty-five years old 
(U.S. Census Bureau, 2018).  As this group ages, they will experience degradations of 
various health aspects; one of which is a decline in cognitive function.  Cognitive 
function is a term encompassing a person’s capacity for learning, memory, and other 
nervous system-driven tasks essential for normal, functional living (Albert, 1997).  When 
cognitive function begins to decline, activities of daily living (ADLs) become 
increasingly difficult if not impossible.  It is this incapability to perform ADLs that often 
results in a dementia diagnosis.     
 Cognitive decline is exceedingly prevalent in the aging population.  Cognitive 
decline will present itself in much of the elderly population as a reduced ability to learn 
or to remember (Albert, 1997).  In the United States, 1 in 9 people over the age of sixty-
five report confusion or memory loss (Taylor, 2018).  Often, cognitive decline is the 
result of a neurodegenerative disease (Deuschi, 2009).  As a neurodegenerative disease 
progresses, patients lose the ability to care for themselves.  They cannot feed or clothe 
themselves, and they can even become a hazard to themselves.  Their families are often 
left with the difficult task of finding/providing around-the-clock care for their loved one.  
For many, the solution could be a nursing facility, in-home care, or a move into a 
relative’s home.  Those who do not have family to take care of them are left to rely upon 
Medicare for their end-of-life needs.  Those needs can become quite costly with the 
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various conditions and injuries that tend to accompany dementia.  With Medicare being 
constantly used as a political weapon, its existence is indefinite.  In 2010, it was 
estimated that each adult with dementia accumulated $56,290 in care-related costs 
annually.  Dementia is one of the most expensive pathologies with the total cost for care 
in America reaching $109 billion in 2010; $7 billion more than the national costs related 
to heart disease in that same year (Hurd, 2013).  The economic, sociological, and 
individual burden of dementia would be alleviated by treatments for the above-mentioned 
cognitive decline.   
 None of the treatment options available for cognitive decline have been entirely 
successful.  This failure could be due to incomplete information regarding the aging 
brain.  It is impossible to completely understand cognitive decline if the normal aging 
process itself is not yet entirely understood.  To execute applied research aimed at 
alleviating dementia symptoms, basic research on aging and the brain must first be done 
to help comprehend the cause of those symptoms. 
Effects of Aging on Hippocampus: 
 The hippocampus is the brain region most involved in memory formation, 
retention, and recollection (Scoville, 1957).  Memory loss is one of the key symptoms of 
cognitive decline, and since memory is the main function of the hippocampus, the 
hippocampus is an essential brain region to study in order to understand cognitive decline 
(Wimmer, 2012).  Even in the absence of cognitive decline, the hippocampus undergoes 
structural and functional changes as aging progresses.   
 The aging hippocampus has been shown to experience structural changes which 
negatively impact function. For example, shrinkage of the hippocampus has been linked 
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with memory loss (Erikson, 2011; Schuff, 1998) with the shrinkage being even more 
drastic under dementia-like conditions (Perrson, 2006).  Structural synaptic abnormalities 
in the hippocampus have been associated with increased severity of cognitive decline.  
Specifically, a reduced amount of the protein synaptophysin in hippocampal neurons, is 
linked with worsened abilities to learn or remember (Sze, 1997).  In normal aging, 
dendritic changes in the hippocampus are conducive to plasticity; however, in those 
afflicted with cognitive decline, dendritic proliferation decreases, indicating a reduction 
in neuroplasticity (Flood, 1990).  The structural and biochemical changes of the 
hippocampus experienced during aging engender alterations in hippocampal 
functionality, and therefore cognitive function.  
 Synaptic transmissions are reduced as aging progresses, resulting in less neuronal 
connectivity, possibly contributing to lower abilities of information processing 
(Vanguilder, 2010).  The rate of cognitive decline is directly proportional to the amount 
of hippocampal activation in adults with mild cognitive impairment (Miller, 2008).  
Hippocampal activity implies action potentials and the release of neurotransmitters.  
Neurotransmitters are the molecules of communication released into the synaptic cleft 
following an action potential.  Acetylcholine is a neurotransmitter involved in memory.  
Age-related deficiencies of the cholinergic system within the hippocampus is a known 
contributor to cognitive decline (Gallagher, 1995; Pyapali, 1996).  A reduction of protein 
synthesis in the aging hippocampus has deleterious effects on memory and long-term 
potentiation (Mullany, 1997; Pang, 2004).  Particularly, subunits of the NMDA receptor, 
an ionotropic glutamate receptor involved in memory function, are diminished in aging 
(Eckles-Smith, 2000).   
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 Aside from synaptic abnormalities, aging can cause changes to the general 
structure of the hippocampus.  As aging progresses, the production of novel neurons 
decreases (Apple, 2017).  While the exact function of new neurons in the adult brain is 
unclear, they are implicated to be involved in learning, memory, and plasticity.  Since 
learning and memory are reduced in unsuccessful aging, new neurons are a promising 
avenue to encourage successful aging, and to combat neurodegenerative diseases such as 
Alzheimer’s Disease (Jessberger, 2008; Barnes, 2011).    
Alzheimer’s Disease: 
 Although Alzheimer’s disease (AD) is not the focus of this study, the extensive 
research on AD provides potential mechanisms to study in relation to aging in general.  
Being the most common form of dementia, Alzheimer’s Disease affects over five million 
people in the United States (Mayeux, 2010).  Lapses in memory, reported by the patient 
or the caregiver, are often the primary reason a person with early Alzheimer’s first seeks 
the advice of a physician (Carr, 2000).  Not surprisingly, the hippocampus is the brain 
area first affected by Alzheimer’s.  Hippocampal atrophy occurs before symptoms of 
Alzheimer’s are even expressed (Fox, 1996).  Specifically, the CA1 area of the 
hippocampus atrophies prior to the presentation of symptoms (Apostolova, 2010).  The 
CA1 subregion is involved in contextual memory retrieval; therefore, the atrophy 
experienced is likely a large contributor to the memory deficits seen in Alzheimer’s 
patients (Ji, 2008). 
 Another early event in the progression of AD is neuroinflammation.  In AD, 
neuroinflammation is prompted by the degradation of neurons in the hippocampus, and 
will subsequently promote further hippocampal atrophy (Heneka, 2007).  The cyclic 
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nature of inflammatory effects makes inflammation one of the most detrimental 
mechanisms of AD.  It is arguably the largest contributor to AD pathogenesis (Akiyama, 
2000).  Anti-inflammatories such as NSAIDs have been tentatively shown to prevent the 
onset of Alzheimer’s disease (McGreer, 1996).  Attempts to directly target the cells 
involved in inflammation are underway, but none have proved entirely successful (Seo, 
2018).  Inflammatory changes happen even in normal aging of the hippocampus.  As 
aging progresses, pro-inflammatory chemicals are increased while anti-inflammatory 
chemicals are decreased, resulting in an overall increase of inflammation which makes 
the brain more susceptible to neurodegenerative diseases, cognitive decline, and memory 
dysfunction (Silva, 2013).   
 As a result of the increased inflammation within the hippocampus during the 
progression of AD, neurogenesis decreases (Lazarov, 2010).  Neurogenesis is a 
mechanism of neuroplasticity, so a decline in neurogenesis could explain some of the 
cognitive deficits seen in Alzheimer’s Disease.  Reversing this decline in neurogenesis 
has been examined as an avenue of treatment for AD.  Increasing neurogenesis could 
potentially replace the neurons lost over the course of AD, or at least mitigate the effects 
of neuronal atrophy (Kunlin, 2004).  Clinical trials for a neurosteroid, a drug used to 
promote neurogenesis, are proving hopeful in combating AD (Chen, 2018).  Even in the 
absence of a neurodegenerative disease, promoting neurogenesis could help facilitate 
successful aging.  
Neurogenesis:  
 It is widely understood that after the embryonic and early postnatal period, lost 
neurons will not be innately replaced.  Yes, the brain will compensate for the death of a 
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neuron to retain function, but in the case of neurodegenerative diseases, injuries, and 
widespread atrophy, this compensation is often not adequate to maintain a normal level of 
function (Grade, 2017).  Some areas of the brain have more compensatory mechanisms 
than others.  The dentate gyrus, in particular has been extensively studied for its unique 
ability to produce new neurons throughout adulthood (Altman, 1965). 
 The dentate gyrus (DG) is the region within the hippocampus believed to be the 
first location on the path to episodic memory within the hippocampus (Amaral, 2008).  
The DG receives information from the entorhinal cortex, and sends the received 
information to the CA3 area of the hippocampus for further processing.  The structure of 
the dentate gyrus is important to recognize when considering its functions.  The DG is 
made of three layers.  The molecular layer holds the extensions from the entorhinal 
cortex as well as the dendrites of granule cells.  The polymorphic layer houses mossy 
fibers, unmyelinated axons of granule cells.  The largest layer is the granule cell layer.  
As its name suggests, the granule cell layer is made of the cell bodies of granule cells and 
is the area of interest when considering neurogenesis (Amaral, 2008).   
 It is the granule cells of the dentate gyrus that can be created throughout the 
lifetime.  The process of neurogenesis occurs in the subgranular zone of the dentate gyrus 
(Altman, 1965).  It is in the subgranular cells that precursor cells are found.  The 
precursor cells develop to form granular neurons to occupy the granular zone.  GFAP+ 
astrocytes are involved in precursor cell proliferation and differentiation (Ming, 2005).  
Astrocytes may even be the precursor cells found in the subgranular zone (Doestch, 1999; 
Seri, 2001).  Once the precursor cell is formed from the astrocyte, the cell’s fate must be 
decided.  Glial cells are cells that support the neuronal function of the brain, and 
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gliogenesis occurs throughout the nervous system for the duration of a mammal’s life.  A 
precursor cell can either become a glial cell or a neuron.  When exposed to bone 
morphogenic protein, the precursor cell will become a glial cell (Campanellia, 2008).  
Since the astrocytes in the subgranular zone secrete neurogenesin-1, a bone morphogenic 
protein antagonist, the precursor cells will become neurons, not glial cells (Ueki, 2003).  
Once the precursor cell, becomes a neuroblast, it migrates to the granular zone where it 
continues to mature.   
  As neurogenesis is a naturally-occurring process, it must have functional 
relevance.  Determining that functional relevance has been the aim of neuroscientists 
around the world for the past fifty years.  Several hypotheses have permeated the 
literature.  The most popular of these is the idea that the new neurons contribute to 
learning and memory (Ming, 2005).  New neurons certainly contribute to neuroplasticity, 
and plasticity is a mechanism of learning and memory, so this theory is well-founded.  
 Some clues as to the function of neurogenesis lie in the mechanisms that influence 
it.  Exercise and learning can increase neuronal production (Fabel, 2009).  Aging reduces 
the number of novel granule cells in the hippocampus (Apple, 2017).  In older adults, 
neurogenesis has been found to be reduced by up to 80% of that experienced in younger 
adults (Riddle, 2007).   This reduction of neurogenesis could contribute to the cognitive 
impairment that older individuals experience more often than their younger counterparts.  
This, and the fact that neurogenesis could be used to reverse neurodegeneration, makes it 
an essential mechanism to study.   
 Studying neurogenesis is not a simple task.  Studying neurogenesis in humans is 
difficult, because often immunocytochemistry and Western Blot are the techniques used 
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to determine the amount and location of neurogenesis.  Both techniques require tissue to 
be removed from the organism in a manner that preserves the protein composition of 
cells.  Inevitably, the organism must be sacrificed for the purpose of science, something 
completely unethical to do to a human.  Additionally, animal models have been created 
that can manipulate neurogenesis, or the factors that influence it, to better determine 
causation without extensive confounding variables.  Directly manipulating the brain of a 
human in this manner is unethical. 
TK Model: 
 Amazing advancements in medicine and neurological knowledge have been made 
over the past century.  Much of this progress was made using rats.  Rats were the very 
first mammal used for scientific research beginning in the 1850s (Jacob, 1999).  Using 
rats to model humans in research provides several advantages.  Rats have shorter 
lifespans than humans, so research projects with rats are much more efficient.  
Additionally, rats are genetically similar to humans, allowing for human conditions to be 
modelled in rats.  For example, a strain of rats has been bred to exhibit an Alzheimer’s-
like pathology (Vandamme, 2014).  Using rats enables scientists to make structural or 
chemical manipulations that would be unethical to make in the brain of a human.  Since 
the brains of rats have many of the same processes and connections as human brains, the 
results of a rat experiment can be postulated to be true in the human brain.  Thus, through 
studying the rat brain, the mechanisms of the human brain become more clear. 
 Rats are especially useful in studying neurogenesis, given that up to 9,000 new 
neurons can be created in the adult rat hippocampus each (Cameron, 2001).  Thus, a 
transgenic rat model designed to model an inhibition of neurogenesis has been created.  
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Inhibiting neurogenesis allows researchers to gain a better understanding about the 
function and impact of the new neurons on the extracellular environment.  The model 
used to do this involves a transgenic rat with herpes simplex virus thymidine kinase (TK) 
in cells with glial fibrillary acid protein (GFAP+) (Snyder, 2016).  GFAP is found in 
abundance in the progenitor cells that become the new neurons.  Stopping the GFAP-
expressing cells from dividing has been shown to stop the production of new neurons in 
the subgranular zone (Garcia, 2004). So, at eight weeks old, this transgenic model is 
treated with valganciclovir (VGCV).  VGCV is an antiviral treatment that kills cells in 
the S-phase of mitosis if the cell expresses thymidine kinase.  Since only the GFAP cells 
in this model have TK properties, only the GFAP progenitor cells are ablated.  Thus, 
neurogenesis is halted following the VGCV treatment (Schloesser, 2009).  While it is 
GFAP-expressing cells that are targeted, astrocytes remarkably remain unaffected by this 
treatment, making it a true model for stopping the differentiation of stem cells; or 
ablating neurogenesis.  
 In an analysis of the TK hippocampal tissue where neurogenesis was stopped at 
eight weeks, the hippocampus shrunk and dendritic losses were found - not unlike the 
changes that occur in aging (Schoenfeld, 2017).  This indicates that halting neurogenesis 
could potentially hasten the aging process of the hippocampus.  Therefore, there is 
validity in understanding the cellular mechanisms occurring in the TK rats as they age 
without neurogenesis. 
Effects of Inflammation: 
 Inflammation is an immune response to a stressor such as injury, toxins, or 
infection.  Inflammation occurs when immune cells swarm the afflicted area.  The rapid 
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increase of immune-cell presence can “suffocate” neurons and lead to neuronal death.  
Inflammation is increased in the brains of aging individuals.  The term “inflammaging” 
was coined to describe the chronic, low-grade inflammation found in the brains of aging 
individuals (Franceschi, 2007).  One proposed cause for inflammaging is the fact that 
senescent cells release pro-inflammatory cytokines (Chinta, 2015).  A cytokine is a 
signaling protein released by immune system-related cells to regulate inflammation or 
immunity.    
 The constant release of pro-inflammatory cytokines can lead to chronic 
inflammation.  Chronic inflammation has some functional benefits, but it can also be 
detrimental to neurological health.  Low-grade inflammation can induce the activity of 
immune cells in the brain to help fight infection (Deleidi, 2015).  Alternatively, increased 
inflammation has been linked to depression (Loftis, 2008). This could correlate to the 
increased depression experienced by the aging population in contrast to younger groups 
of people (Fiske, 2003).  Inflammation increases with aging, and this causes behavioral 
and cognitive changes.  The regulatory bodies of inflammation in the brain are microglia, 
a type of glial cell.  Glial cells are the supporting cells for the neurons.  They facilitate 
brain health and neuronal function.  Changes to microglial function could impact brain 
health and cognitive function in even normal aging, nevertheless abnormal aging. 
Microglia: 
 Microglia are implicated in both cell generation and cell degeneration in the 
hippocampus through inflammation and phagocytosis.  Microglia are a part of the brain’s 
immune system; they clean cellular debris, and regulate neuroinflammation (Rothwell, 
1995).  Microglia working as phagocytes have been linked with a reduction of synaptic 
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connection (Yoshiyama, 2007).  To regulate inflammation, microglia can be activated to 
produce either pro-inflammatory cytokines or anti-inflammatory cytokines.  For example, 
when activated by liposaccharides, they release pro-inflammatory cytokines such as 
interleukin-18 (IL-18) (Kyoungho, 2000; Rothwell, 1995).  Expression of the genes 
responsible for creating inflammatory factors such as interleukin increase with age 
(Terao, 2002).  If inflammation is higher in the aging brain, as it most often is, then it 
follows that microglia might be more activated as well.   
 Microglia and the regulatory tasks they typically accomplish are affected by 
aging.  As the hippocampus gets older, the number of microglial cells is increased 
(Mouton, 2002); as is the density of microglia in the hippocampus (Gebara, 2013).  The 
amount of debris in the hippocampus due to apoptosis, cell death, is greatly increased, 
and microglia are responsible for the clearing of this debris resulting in an increase of the 
microglial activation ratio (Cerbrai, 2012).   Additionally, microglia were found to be 
more activated in the entorhinal cortex, the main pathway between the hippocampus and 
the neocortex, in humans with Alzheimer’s disease (Cagnin, 2001; Hopperton, 2018).  
This increased microglial activation could be correlated with the increased inflammation 
also experienced by Alzheimer’s disease patients and the aging population in general.   
Microglia’s Effect on Neurogenesis:  
 Microglia’s inflammatory and phagocytic properties also affect neurogenesis.  
Microglia monitor the inflammation of the extracellular environment, and this regulation 
decides if new neurons will live.  Microglia can reduce the number of new neurons 
through phagocytosis; the process of cellular eating.  It has been found that although 
neuron production decreases with age, the proportion of new neurons microglia consume 
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remains the same (Sierra, 2010).  So, despite reduced production, microglia do not allow 
for increased novel neuron survival.  Additionally, microglia in the subgranular zone of 
the dentate gyrus that express presenillin variants (involved in AD) were found to 
negatively impact neurogenesis more than normal (Choi, 2008).   
 Alternatively, microglia have been found to promote neurogenesis under certain 
conditions.  Living in an enriched environment is known to induce increased 
neurogenesis, and this increased neurogenesis is also accompanied by an increase in the 
total number of inactive microglia (Ziv, 2006).  Extracellular environment has also been 
found to influence the effect microglia have on surrounding processes such as 
neurogenesis.  Pro-inflammatory cytokine activated microglia have been found to reduce 
neurogenesis through inflammatory response (Ekdahl, 2003). Alternatively, microglia 
activated by anti-inflammatory cytokines were shown to promote neurogenesis 
(Butovsky, 2005).  Microglia can either restrict or encourage neurogenesis dependent 
upon the activating agent.  But does ongoing neurogenesis regulate microglial activity, 
thus assisting in slowing aging?  This is just one of the countless uncertainties 
surrounding the relationship between microglia and neurogenesis. 
Neurogenesis’s Effect on Microglia: 
 The existing literature is very one-sided in that it focuses on the effect glial cells 
or proteins have on neurogenesis.  The directionality of the relationship between glial 
cells and neurogenesis may seem inconsequential, but a huge gap in research exists when 
attempting to discern how neurogenesis affects the extracellular environment.  This 
presents a problem when considering neural stem cells as a potential route of treatment 
for neurodegenerative diseases like Alzheimer’s.  Inflammation is a key part of 
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Alzheimer’s disease, and since microglia are the regulators of neuroinflammation, it is 
crucial to understand how changes to neurogenesis affect microglial activation.  
Therefore, using the TK rat model, I inhibited neurogenesis for various durations to 
determine how losing the ability to produce new neurons may accelerate the aging 
process through changes of hippocampal volume and microglial activation. 
Hypothesis: 
 I expect both aging and neurogenesis ablation to result in a reduction of 
hippocampal volume and an increase in microglial activation. 
II.  Materials and Methods 
A) Materials 
i) Genotypes and Age Groups 
 A transgenic Long-Evans rat model was used to determine how microglial 
activation and hippocampal volume are affected by neurogenesis and age.  Rat brains 
were donated by Heather Cameron of the National Institute of Mental Health (NIMH).  
Some of these rats had been involved in experiments previously conducted at NIMH, but 
being in control groups, they underwent no experimental manipulation other than the 
genotype manipulation from which this experiment benefits.  Dr. Cameron donated 
thirty-six brains in three different stages of maturity at the time of sacrifice.  The nine rats 
in the young group were twelve weeks old, the eleven in the middle group were twenty-
one weeks old, and the sixteen in the older group were thirty-two weeks old.  Each age 
group contains two conditions.  The experimental group is the transgenic rat with herpes 
simplex virus thymidine kinase (TK) in cells with glial fibrillary acid protein (GFAP+).  
The TK rats in each age group were treated with valganciclovir (VGCV) at 8 weeks old 
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to stop neurogenesis in the subgranular zone of the hippocampus (Snyder, 2016).  Thus, 
the three age groups reflect pharmacological inhibition of adult neurogenesis for 4, 13, 
and 22 weeks, respectively.  The control condition is the wild type (WT) rats.  These rats 
underwent the same VGCV treatment as the TK rats; however, due to an inactive 
transgene, adult neurogenesis is unaffected in WT rats.  Genotypes (WT vs. TK) were 
originally determined through RT-PCR of ear samples, performed and provided by 
Heather Cameron’s lab at the NIMH. 
  Figure 1: Experimental groups 
 
 
 
 
ii) Tissue Retrieval and Staining Devices 
 All brain tissue was preserved though normative fixation procedures using 4% 
paraformaldehyde.  After a long period of fixation, tissue was shipped to Belmont with a 
cryoprotectant, 20% sucrose, from which the tissue was processed for 
immunohistochemical staining and microscopy analysis.  Once thoroughly cryoprotected, 
the brains were separated into two hemispheres; one of which remained in the 
cryoprotectant for use in later studies.  The remaining hemisphere was cut into three 
coronal sections.  The anterior and posterior sections were deposited back into the 
cryoprotectant.  The middle piece containing the hippocampal area of interest was sliced 
using a sliding Microtome (American Optical).  The 40 m thick slices were 
systematically placed into a 12-well plate filled with phosphate buffer solution (PBS) to 
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obtain twelve representative samples of brain tissue.  These samples were stored in the 
PBS-filled well plates until staining. 
B) Methods 
i) Verifying Genotype 
  Representative slices of the entire hippocampus from each brain were processed 
with a Doublecortin (DCX) antibody (Cell Signaling Technologies) to verify the 
genotype.  DCX is an endogenous protein marker of immature neurons, so WT rats 
should have ambient DCX expression within the hippocampus, while TK rats should 
have complete inhibition of DCX expression.  To begin, the tissue underwent three rinses 
in PBS.  Once rinsed, the tissue was soaked in a blocking agent comprised of a dilution of 
Tween20 (ThermoFisher Scientific) in PBS (1:5) and normal donkey serum (Millipore 
Sigma).  The tissue soaked in the blocking agent for twenty minutes at room temperature 
to improve the signal-to-noise ratio.  It was immediately moved to the primary stain.  
This primary stain consisted of PBS and Rabbit anti-DCX primary antibody.  The tissue 
soaked in the primary stain for five days at 4C following which it was rinsed in PBS 
three more times.  The tissue then soaked in the fluorescent secondary antibody solution 
(ThermoFisher Scientific) for one hour in the dark at room temperature.  From this point 
on the tissue was kept in the dark as much as possible using aluminum foil wrapped 
around the well plates to maintain the integrity of the fluorescence.  After an hour passed, 
the tissue was again rinsed by PBS before being immersed in a Hoescht stain 
(ThermoFisher Scientific) at a 1:1000 ratio with PBS for ten minutes.  The process 
concluded with a final three rinses of PBS.  The hippocampal tissue was then mounted 
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onto frosted microscope slides, cover slipped using glycerol (70%), and sealed using 
clear nail polish. 
 Doublecortin is a protein expressed in immature neurons, and the DCX stain 
illuminates immature neurons visible under a fluorescent microscope.  The presence of 
new neurons in tissue either confirms that the rat was a WT rat, or refutes the validity of 
the TK rat.  The DCX stain verified the genotype of each brain, and the Hoescht stain 
provided a background of cell-bodies.  An epifluorescent BX-51 microscope (Olympus) 
was used for histological analysis of tissue stained with fluorescent antibodies.   The 
DCX stain showed new neurons in the dentate gyrus formation as bright green, and any 
tissue with neurogenesis were recorded as being a WT rat.  The TK rats treated with 
valganciclovir should not show any new neurons with the DCX stain.  Presence of DCX 
staining in TK-genotyped rats can mean either an error in genotyping, drug treatment, or 
immunohistochemical reaction.  To rule out the last option, staining was reperformed on 
any potential false positive tissue.  Otherwise, TK tissue with positive DCX staining were 
to be thrown out from analysis. 
ii) Measuring Hippocampal Volume 
 A cresyl violet (Sigma) stain was used for hippocampal volume analysis.  Ten 
hippocampal slices from one well containing a full representation of each brain were 
mounted on SupraFrost slides (ThermoFisher Scientific).  These slides were left to dry 
overnight.  Once dry, the slides were moved under a fume hood, placed in a vertical slide 
holder, and dipped in 250 mL of double-deionized water.  The slide holder was soaked in 
250mL of cresyl violet stain for approximately six minutes.  Following incubation, the 
tissue underwent a series of increasing concentrations of ethanol; starting with 50% and 
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ending with 100% (with the 70% interval containing one drop of acetic acid).  The slides 
were soaked in the clearing solution, Xylene.  Once five minutes had passed, slides were 
cover-slipped using Permount and allowed to dry overnight before removal from the 
hood for analysis.   
 The cresyl violet stain can be viewed under a BX-45 light microscope (Olympus).   
Seven hippocampal images of each brain were captured at a 4x objective(figure 2). These 
images were then analyzed using the software ImageJ (NIH).  This software allowed for 
the entirety of the hippocampal slices to be traced and calculated an area for each traced 
section.  The hippocampal areas of the seven images from each brain were recalculated to 
be a volume based on the thickness of each slice (40 m), and these values were averaged 
to obtain an estimated value for hippocampal volume of each brain which were then 
compared across genotypes and age groups.  
Figure 2: Cresyl Violet-stained hippocampus 
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iii) Determining Microglial Activation 
 When microglia are activated, they become smaller and more amoeboid.  Ionized 
calcium-binding adaptor molecule-1 (iba1) is a marker expressed by all microglia 
regardless of activation level (Figure 3).  Staining iba1 molecules would allow for the 
morphology of the microglia to be analyzed.  Iba1 staining is conducted through an 
immunofluorescent reaction, meaning that similar to the DCX reaction, a primary and 
secondary antibody was be used.  In addition to the iba1 stain, a Hoescht stain was 
conducted on all tissue to provide a background and ease navigation during analysis.   
 To begin the staining process, representative sample from each brain was rinsed 
three times with PBS.  The tissue was then placed in a blocking solution consisting of 25 
L 20% Tween-20 and 30 L normal donkey serum for every 1mL of PBS.  The tissue 
remained in this solution at room temperature for twenty minutes after which it was 
transferred directly into the primary stain.  The primary stain is 1:500 rabbit anti-iba1 in 
blocking solution.  The tissue remained in the primary stain overnight at 4C.  The tissue 
was rinsed in PBS three times before being placed in the secondary antibody solution 
which consisted of 5L Donkey anti-rabbit Alexa 488 (Invitrogen) for every 1mL of 
PBS.  Once in the secondary solution, the well plate was wrapped in aluminum foil to 
maintain the integrity of the fluorescence.  After one hour of incubation in the secondary 
solution at room temperature, the tissue was rinsed in PBS three times, and Hoescht 
stained.  The tissue was then mounted onto frosted slides, cover-slipped with glycerol, 
and sealed with clear nail polish. 
  The morphology of the microglia could then be measured by tracing the area of 
each microglia using ImageJ (NIH).  Microglia shrink their processes and become 
 20 
amoeboid in shape when activated, so reduction in microglia morphology is one 
indication of microglia activation.  Additionally, when viewed from a lower objective, 
the density of microglia in the area surrounding the dentate gyrus can be measured.  The 
amount of microglia in an area could be indicative of the amount of work they are 
conducting in that area.  
 
Figure 3: Iba1 stain 
 
 
iv) Statistical Analysis 
 A 2x3 (TK/WT x Age) between-subjects ANOVA test was the statistic run for 
each dependent variable (microglia morphology/density and hippocampal volume) using 
SPSS.  Each ANOVA test revealed the interaction between aging and reduced 
neurogenesis on the dependent variables.  We expected to see the oldest TK group exhibit 
the most microglial activation within the dentate gyrus while also demonstrating the 
smallest hippocampal volume.  
III. Results  
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Verifying Genotype: 
 Genotypes were verified using a blind analysis of the DCX stained tissue.  The 
genotype of each brain was verified, and no exclusions were necessary.  Figure 4 shows 
the visual contrast between a DCX-positive cell and a DCX-negative cell.  The new 
neurons born in the WT group show up as a bright green.  This makes the WT dentate 
gyrus easily distinguishable from the dull, TK dentate gyrus that has no bright staining 
other than the Hoescht cell-body staining used to show the structure of the DG.  
Figure 4: TK vs. WT DCX stain 
 
 
 
 
 
 
 
 
 
 
 
Hippocampal Volume: 
 In order to examine the effects of neurogenesis ablation and age on hippocampal 
volume, hippocampal volume from all six treatment groups was obtained using ImageJ 
and analyzed with a 2x3 (genotype x age) between-subjects ANOVA.  There was no 
main effect of genotype (F1,29 = .77, p = .39), but a significant main effect of age (F2,29 = 
Wild-type genotype 
TK genotype 
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4.50, p = .02).  Tukey’s post-hoc tests showed that hippocampal volume was decreased in 
the oldest group, compared to the youngest group (p < .05) as shown in Figure 5.  Lastly, 
there was no significant genotype x age interaction on hippocampal volume (F2,29 = 1.51, 
p = .24).   
 
 
 
Determining Microglial Activation: 
 It was visually obvious that the microglial density was much higher in the 
younger rats than the older group even before statistical analyses took place.  The images 
below demonstrate the disparity between the amount of microglia in each age group. 
Figure 6: Microglial Density 
4 Weeks VGC 22 Weeks VGC 13 Weeks VGC 
Figure 5: Effect of Age on Hippocampal Volume.  Hippocampal volume was not 
affected by inhibiting neurogenesis, but age did have a significant effect between the 
oldest and youngest groups.  Error bars represent S.E.M. * p < .05. 
VGC 
VGC 
VGC 
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 To determine the effects of neurogenesis ablation and age on microglia density 
within the hippocampus, iba1-stained microglia from all six treatment groups were 
counted and compared across groups using a 2x3 (genotype x age) between-subjects 
ANOVA.  There was no main effect of genotype (F1,29 = .12, p = .73), but a significant 
main effect of age (F2,29 = 4.06, p = .03).  Tukey’s post-hoc tests showed that microglial 
density was decreased in the oldest group, compared to the youngest group (p < .05) as 
shown in Figure 7.  Lastly, there was no significant genotype x age interaction on 
microglial density (F2,29 = .31, p = .74).   
 
 
 
 In addition to influencing microglial density, aging also affected the area of the 
microglia found in the dentate gyrus.  Changes in microglia morphology implicate 
Figure 7: Effect of Age on Microglial Density: Microglial density was not affected 
by inhibiting neurogenesis, but age did have a significant effect between the oldest 
and youngest groups.  Error bars represent S.E.M. * p < .05 
VGC 
VGC 
VGC 
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changes in microglial activation.  Since activated microglia are smaller than quiescent 
microglia, smaller microglial area implies more microglial activation.  To determine the 
effects of neurogenesis ablation and age on microglia activation, microglia areas from all 
six treatment groups were obtained using ImageJ and analyzed with a 2x3 (genotype x 
age) between-subjects ANOVA.  There was no main effect of genotype (F1,29 = 2.14, p = 
.15), but a significant main effect of age (F2,29 = 15.78, p < .001).  Tukey’s post-hoc tests 
showed that microglia area was decreased in the oldest group, compared to the youngest 
group (p < .01), and the middle group compared the youngest group (p < .001) as shown 
in Figure 8.  Lastly, there was no significant genotype x age interaction on microglia 
area/activation (F2,29 =2.40, p=.11).   
   
 
 
 
 
Figure 8: Effect of Age on Microglia Area: Microglia area was not affected 
by inhibiting neurogenesis, but age did have a significant effect between the 
oldest and the youngest groups as well as the middle and the youngest groups.  
Error bars represent S.E.M., * p < .05, *** p < .001. 
VGC 
VGC 
VGC 
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IV. Discussion 
 The results of each measure indicate that stopping new neurons from growing has 
no significant effect on the brain’s immune system in the dentate gyrus.  Completely 
inhibiting neurogenesis had no effect on hippocampal volume or microglia 
activity/density.  While neurogenesis did not correlate with any of the measures, aging 
negatively affected all three (hippocampal volume, microglial area, and microglial 
density).  Despite the significant effects of aging, there was no interaction between 
neurogenesis loss and aging, meaning that the ablation of neurogenesis may not be an 
adequate model for aging. 
 As seen in figure 5, aging had a significant effect on hippocampal volume.  The 
oldest brains of both genotypes had the smallest volumes while the youngest brains had 
the largest.  Decline in hippocampal volume has been linked with the decline in spatial 
learning and memory often experienced during aging (Hamazeh, 2017). The exact cause 
of hippocampal shrinkage in late adulthood remains unclear.   
 One proposed mechanism for the reduction of hippocampal volume involves 
brain-derived neurotropic factor.  Lower levels of brain-derived neurotropic factor 
(BDNF), a neuron growth and proliferation promoter, have been linked with the reduced 
hippocampal volume (Erickson, 2010).  BDNF is essential for successful hippocampal 
neurogenesis (Rossi, 2006).  Increasing BDNF levels increases the amount of new 
neurons (Scharfman, 2005).  Reducing BDNF levels reduces differentiation of new 
neurons following neurogenesis (Taliaz, 2009). BDNF affects neurogenesis, and 
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neurogenesis maintains hippocampal volume; perhaps it is the reduction of BDNF that 
causes a reduction of neurogenesis that results in a smaller hippocampal volume. 
 Since neurogenesis did not affect hippocampal volume in this experiment, an 
alternative explanation for hippocampal shrinkage has been found. Microglia regulate 
inflammation within the brain.  As hippocampal brain cells age, they release pro-
inflammatory cytokines (Chinta, 2015).  This causes an increase in microglia presence 
within the hippocampus as aging progresses (Gebara, 2013).   More microglia in the 
hippocampus leads to more inflammation, causing cell death.  Cell death causes more 
microglial activation due to the phagocytic nature of microglia (Cerbrai, 2012).  The 
cycle of microglial upregulation causing neuronal death causing microglial upregulation 
is also a possible mechanism for the reduction of hippocampal volume in the aging brain.  
It is possible to end this cycle, at least in an animal model.  The overreactive microglia 
population could be eliminated by inhibiting colony-stimulating factor 1 receptors, 
receptors necessary for microglial survival.  The inhibition can then be removed, and the 
microglia allowed to repopulate.  The new microglia do not show the aggressive 
behaviors of the old, and increases in neurogenesis, synaptic complexity, and 
hippocampal volume follow this treatment (Elmore, 2018).    
 It was expected that both microglia density and activation would increase as age 
increased (Gebara, 2013; Elmore, 2018; Kaneshwaran, 2019).  Microglia density 
typically increases in areas experiencing inflammation or cell death such as the aging 
hippocampus (Pearson-Leary, 2017).  Microglial activation, measured by the morphology 
of the microglia, typically increases with age as well (Mangold, 2017).  Increases in 
microglial density and activation typically happen in conjunction (Appel, 2018; Gebara, 
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2013 ).  The oldest rats did express the most microglial activation, as was expected, but 
they also had the least microglial density.  While the cause of these results is unclear, two 
hypotheses as to why there might be fewer, but more activated microglia in the oldest age 
group, barring experimental error, emerged upon further examination of the literature.   
 Experimental error is the first thing to consider when attempting to explain the 
discrepancy in our results.  The density of microglia in the area surrounding the dentate 
gyrus was significantly lower in the older age group indicating that despite the microglia 
being more activated in the older age group, there were less microglia present in the 
hippocampus.  One explanation for this could have been that the 10x magnification was 
too wide to view the much smaller, activated microglia as opposed to the larger microglia 
of the younger rats. 
 Microglia in the hippocampus remain in a more immune-vigilant state than 
microglia in the rest of the nervous system (Grabert, 2016).  Microglia are especially 
primed for an immune response in aging (Perry, 2013).  Perhaps at the time of sacrifice, 
the microglia in the hippocampus of the aged rats had just begun an immune response, 
making them more activated, but not yet increased in number.  
 Microglia have a relatively long lifespan compared to other glial cells (~4 years), 
but a third of the brain’s microglial population are still replenished each year (Reu, 2017).   
Interferon regulatory factor 8 (IRF-8) is protein essential for the development of 
microglia.  In a mouse model with reduced IRF-8, microglial density was also reduced 
(Kierdorf, 2013; Yin, 2017).  IRF-8 is found to be reduced with aging (Zhou, 2019).  
Since aging causes a reduction of IRF-8 and a reduction of IRF-8 causes a decrease in 
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microglial density, this could explain the small density found in the aged rats despite the 
greater activation.   
 One final hypothesis for the concurrent smaller microglia and smaller amount of 
microglia in the oldest age group could be microglial senescence.  Microglia themselves 
experience functional and structural changes associated with senescence (Spittau, 2017).  
Most notably, microglia become dystrophic as they undergo senescence; meaning they 
lose the processes that greatly contribute to their area, making them appear more 
activated when in fact they are just senescing (Luo, 2010).  Further analysis of the tissue 
is needed to confirm any of these hypotheses. 
 The effects of aging on microglial activation, density, and hippocampal volume 
were significant, but the ablation of neurogenesis did not have a significant effect on any 
measure regardless of duration.  Looking at previous studies, the TK rats should have 
shown a smaller hippocampal volume than the WT rats (Schoenfeld, 2017).  One 
potential confound of this study could have been where the volume was analyzed.  
Representative slices of the entire hippocampus were measured and considered in the 
overall volume.  Neurogenesis only occurs in the dentate gyrus, so if neurogenesis is 
ablated it might have only caused a shrinkage of the dentate gyrus, and not the entire 
hippocampus.  Thus, measuring the entire hippocampus instead of just the dentate gyrus 
may have diluted any dentate shrinkage caused by the prolonged ablation of 
neurogenesis. 
 The TK rats also did not show a change in microglial activation.  It was 
hypothesized that reducing neurogenesis might increase microglial activation in the 
dentate gyrus because of the apoptosis of the proliferating neurons due to the VGC 
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treatment.  However, no change to microglial activation was found, other than that linked 
to aging.  In a previous study using the same transgenetic model, there was no TK effect 
on astrocytes (Snyder, 2016).  This suggests that the ablation of neurogenesis may just 
have no effect on glial cells.  Additionally, since microglia have both positive and 
negative regulatory effects on neurogenesis, these processes could be neutralizing, and 
completely removing neurogenesis would not change the overall “work” of the microglia 
(Morrens, 2011).  Despite neurogenesis ablation not affecting microglial activation, 
reductions in neurogenesis, as seen during aging, have other implications. 
      Neurons born in the developed dentate gyrus are important for spatial problem 
solving, learning, pattern separation, and mood regulation (Seib, 2015; Snyder, 2016).  
Aging is linked with changes in hormones such as greater levels of glucocorticoids, stress 
hormones.  Increasing glucocorticoids reduces neuronal birth in the dentate gyrus (Veena, 
2011).  The reduction of neurogenesis in aging leads to a reduction of the beneficial 
effects of neurogenesis:  plasticity, learning, memory, and mood regulation.  
Neurogenesis was found to be reduced by up to 80% in aged rats (Jen, 2003).  The largest 
implication of this reduced neurogenesis is cognitive decline.  Excessive decline in 
neurogenesis is linked with increased risk for dementia (Mathews, 2017). 
 Microglial activation is also associated with an increased risk for dementia.   
Microglial activation is caused by neuronal death, blood-brain barrier disruption, or 
invading lymphocytes (Finch, 2002).  Typically, microglial activation increases with age, 
as supported by the results of this experiment (Mouton, 2002).  It is the changes that 
accompany senescence that causes microglia to go from neuroprotective in youthful 
individual to neurotoxic in older individuals (Luo, 2010).  Specifically, the chronic 
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inflammation that occurs during aging results in an overactivation of microglia that 
negatively impacts learning and memory.  The overactivation of microglial becomes a 
cycle wherein inflammation causes microglial activation which causes inflammation 
which causes more microglial activation, and further declines in learning and memory. 
 Learning and memory deficits are associated with both increased microglial 
activation and decreased neurogenesis during aging.  These deficits can be reversed or 
prevented by targeting either mechanism. The microglial overactivation cycle could 
potentially be broken by consuming an antioxidant-rich diet (Wu, 2016).  Microglial 
activation can also be reduced using herbal compounds such as resveratrol (grapes, 
peanuts, berries), trans-cinnamaldehyde (cinnamon), and curcumin.  These natural 
remedies work mostly through anti-inflammatory methods to reduce microglia activation 
and decrease cognitive decline (Fu, 2018).  Increasing neurogenesis, or preventing its 
reduction is an alternative method of staving off learning and memory deficits.  Exercise 
has been shown to increase neurogenesis to near-normal levels in aged subjects (Fabel, 
2009; Erikson, 2011).  Exercise is useful to neurogenesis by increasing BDNF levels and 
blood flow to the neurogenic niche (Sieb, 2015).  Exercise is currently the least invasive 
treatment with the most potential to reverse/prevent cognitive decline in humans.  A more 
invasive option for reversing neurogenesis-related cognitive decline involves chemically 
targeting stress-induced changes to the hippocampal protein composition.  This method 
has been shown to counteract neurogenesis reduction and the cognitive decline that this 
reduction induces (Seib, 2013).  Cognitive decline is a huge problem associated with 
aging, but mechanisms designed to promote neurogenesis and reduce microglial 
activation have proved useful in mitigating the effects of aging. 
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V. Literature Review: Response to Senescence and Mortality  
 In the absence of events or illnesses leading to a premature abbreviation of life, 
senescence is inevitable for almost all organisms.  Humans have the privilege of being 
the only organisms to be cognitively aware of their inevitable decline in function, 
fertility, and ultimate mortality.  The response to such knowledge is different for each 
person or group with cultural values influencing a person’s attitude towards impending 
death (Howard, 1965).  Societal responses to mortality and senescence include 
stereotyping aging individuals, increasing research efforts, and adjusting life to 
accommodate those experiencing senescence. 
Stereotyping 
 Age stereotyping is not only a poor system for understanding people of different 
demographics but can also have detrimental effects for those experiencing the 
stereotyping (Levy, 2009).  In one study surveying people over sixty-five years old, 84% 
of the participants had experienced some form of ageism (McGuire, 2008).  Holding age-
related stereotypes contributes to a phenomenon referred to as the “Generation Gap,” a 
divide between members of different generations resulting in decreased ability to exist 
cohesively within the same environment (Wood, 2005).  Age stereotypes not only affect 
relationships between members of different generations, but also influence those targeted 
by the stereotype.  When primed with a negative age-related stereotype, aging people 
perform worse on both memory and physical tasks (Hess, 2003; Emile, 2014). Self-
stereotyping can be influential in the aging process.  People who hold positive beliefs and 
attitudes about aging were found to live an average of 7.5 years longer than people with 
negative concepts regarding aging (Levy, 2000).  Holding negative age stereotypes about 
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oneself can also impact a person’s self-concept, an important aspect of mental wellness 
(Zhang,2017).  Stereotypes are abundant throughout society, and they can greatly impact 
peoples’ attitudes towards their own, and other’s journey through senescence and 
mortality. 
 Ageism can be combatted through several different methods, but it will never 
fully be eradicated as humanity’s underlying fear of death breeds prejudice against those 
closest to it. Intergenerational connections, group setting in which older generations 
interact with younger generations, were shown to decrease ageist attitudes (Grefe, 2011).  
Education is one of society’s most powerful tools.  Implementing curriculum designed to 
dispel myths about aging improved students’ attitudes toward aging and older people 
(Gleberzon, 2002).  Ageism is especially pronounced in the workplace, but implementing 
mentoring and awareness programs help to reduce corporate age discrimination (Gibson, 
2010).  Stereotypes surrounding aging will continue to prevail as will research aimed to 
combat these harmful stereotypes. 
Researching 
 The endless cycle of aging and dying has undoubtedly led to endless research 
studies aimed at understanding, improving, and preventing senescence.  Various health 
problems accompany aging with some being more serious than others.  Even in 
“successful aging,” aging undergone without concurrent disease, death is inevitable 
(Rowe, 1997).  Thus, even “normal” aging is studied extensively by researchers around 
the world. 
 While aging undoubtedly impacts the entire body, its effect on the brain is 
perhaps the most devastating.  In order to understand how aging directly influences the 
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brain’s structure and function, researchers have turned to animal models.  With animal 
models, researchers overcome ethical and technical restrictions posed by studying 
humans.  With animals, researchers can directly manipulate the brain’s structure, or 
genetically modify the organism to experience the disease or condition of interest.  
Manny different animals have been used in the endeavor to understand aging, with each 
species having its own benefits.  Aging canines have neurological and psychological 
changes like that of humans including -amyloid deposition and age-related cognitive 
dysfunction; however, they do not experience neurofibrillary tangles, making them useful 
only as models for early aging (Cummings, 1996).  Mice models have proved endlessly 
useful in researching both normal and diseased aging.  Often, it can be costly and time-
consuming to wait for an animal model to reach an age appropriate for an aging study.  
To alleviate the cost and time burden, a mouse model that ages rapidly has been created.  
The Senescence-Accelerated Mouse strains (SAM) experience pathological and structural 
changes like that seen in humans, such as decline in learning in memory, but at a faster 
rate than typical mice (Hosokawa, 1999).  Using rodents, researchers can do things such 
as induce DNA breakage or ablate neurogenesis to learn how these occurrences might 
contribute to aging effects in humans (Katyal, 2008; Schoenfeld, 2017).   
 In addition to using animal models to understand the aging brain, research has 
been done on both humans and animals aiming to prevent the effects of senescence from 
occurring.  Cognition is a person’s capability for learning, memory, and other nervous-
system driven tasks essential for normative, functional living (Albert, 1997).  Losing 
cognitive function is a prevalent fear amongst the aging population, thus preventing this 
loss from occurring is the goal for which many neuroscientists are striving.  The exact 
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cause of the cognitive decline has proved difficult to pinpoint.  Abnormalities in the 
neurotransmitter, serotonin (5-HT), have been studied as a potential cause for cognitive 
decline.  Specifically, in the hippocampus, serotonin was found to have reduced 
postsynaptic effects in an aged model (Baskys, 1987).  5-HT uptake inhibitors were 
found to improve memory in aging subjects likely due to the prolonged presence of 
serotonin in the synaptic cleft, allowing for normal postsynaptic action to occur 
(McEntee, 1991).   Additionally, cognitive decline has been associated with increased 
hippocampal activation.  A mouse model with increased hippocampal activation was 
treated with levetiracetam, an antiepileptic drug to reduce overactivation.  Following the 
treatment, the mice experienced a reversal in cognitive decline when treated early enough 
(Devi, 2013).  Serotonin and levetiracetam are only two of the countless 
mechanisms/treatments being studied in hopes of preventing/reducing cognitive decline.   
 While pharmacological substances have proved useful in preventing senescence, a 
person’s life-style can also play a role in their well-being as they age.  Diets, regimens, 
and specific foods have been found to have anti-aging qualities.  Dark chocolate, fish, 
vegetables, nuts, and garlic are among the foods being proclaimed as anti-aging largely 
due to their anti-oxidant and anti-inflammatory properties (Sabate, 2010; Corti, 2009; 
McAllister Pryade, 2011).  Specifically, a Mediterranean diet, a diet containing foods 
high in monounsaturated fatty acids, has been linked with lower mortality, and less 
instances of neurodegenerative or cardiovascular disease (Chrysohoou, 2013).  
Restricting calories has shown to correlate with a longer life, delayed senescence, and 
reduced risk for chronic diseases.  While restricting calorie intake can prove to be a 
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difficult regimen to implement, introducing aerobic activities can have the same 
beneficial effects (McCartney, 2012).  
 Research has undoubtedly proved successful since the human lifespan continues 
to rise, and longevity has become mankind’s greatest achievement (Kirkwood, 2008).  
With the population living longer, the elderly population is growing larger and larger.  A 
growing number of people out of the workforce with increased health problems has 
caused a need for social accommodations for these people.   
Accommodating 
 Geriatric Americans are becoming a much larger portion of the United States’ 
population. The 2018 U.S. Census estimated that 15.6% of the population is over the age 
of sixty-five.  This number translates to over 51 million people in the United States over 
sixty-five years old (U.S. Census Bureau, 2018).  Sixty-five years is the average age of 
retirement for people in America, and accommodations have had to be made to facilitate 
the housing and care of the growing elderly population.  The most notable 
accommodation came from the United States government: Medicare. 
 In the 1950s and 60s, the newly formed health insurance companies were 
reluctant to insure people over sixty-five.  In fact, in 1961 56% of people over sixty-five 
did not have health insurance.  It was not until 1966 that Medicare health coverage was 
provided to beneficiaries over sixty-five years old.  By 2019, 60.6 Medicare had 60.6 
beneficiaries costing $705.9 billion.  Medicare has undoubtedly helped millions of aging 
Americans in its fifty years of existence, but it is anticipated that the Medicare Part A 
trust fund will be depleted by 2026 (Medicare Resources, 2019).  Following the 
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depletion, claims filed will have to be covered by payroll taxes, an amount insufficient to 
support the health needs of the growing elderly population.  
 The lack of funding for healthcare for the elderly is especially concerning since 
the average life expectancy is projected to exceed ninety years for women by 2030 
(Kontis, 2017).  With people expected to continue living older, their quality of life in 
their old age must be taken into consideration.  Factors essential to a maintaining good 
quality of life in aging include: nutrition, relative involvement, minimal physical 
problems, love and attachment, continued learning, and attitude towards aging 
(Imanzadeh, 2018).  Life is not quantifiable, but the quality of it seems to be so.  
Unfortunately, quality of life for the aging seems to be on a decline (Gurwitz, 2019).  
Efforts have been made to improve quality of life in both chronically ill and healthy 
individuals.  Combining dance and relaxation therapy has shown to reduce depression 
and anxiety thereby improving the quality of life of elderly patients (Adam, 2016).  
Alternatively, pet therapy has proved hopeful in bettering the lives of the aging 
(Meretti,2010).  Accommodating the growing aging population is a challenge, but with 
economic and therapeutic adaptions, aging can be made a more comfortable experience. 
 Each person’s experience and attitude towards their own mortality is unique, but 
societal responses to senescence are widespread.  Stigmas surrounding the elderly are 
prevalent, as are research endeavors to understand the aging process, and efforts aimed at 
improving it.  Endless are the questions and uncertainties surrounding aging, and endless 
will be the endeavor to prevent and improve the process.    
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